Valeant Pharmaceuticals Intern... : VRX

All VRX Articles

185 Articles

Paul Ausick | Mar 16, 2016 at 4:04 PM EDT

The 52-Week Low Club for Wednesday

March 16, 2016: Here are four stocks trading with heavy volume among 53 equities making new 52-week lows in Wednesday’s…

Jon C. Ogg | Mar 16, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Chipotle, Oracle, Orexigen, PulteGroup, Reynolds American, Valeant and More

The top analyst upgrades, downgrades and initiations seen on Wednesday, March 16, include Chipotle Mexican Grill, Oracle, Orexigen Therapeutics, PulteGroup,…

Douglas A. McIntyre | Mar 16, 2016 at 6:47 AM EDT

Valeant CEO Michael Pearson Has to Leave

CEO Michael Pearson needs to leave Valeant Pharmaceuticals for it to have any chance to recover. The company cannot afford…

Paul Ausick | Mar 15, 2016 at 4:04 PM EDT

The 52-Week Low Club for Tuesday

March 15, 2016: Here are four stocks trading with heavy volume among 33 equities making new 52-week lows in Tuesday’s…

Chris Lange | Mar 15, 2016 at 10:05 AM EDT

Valeant Pharma Trips Over Preliminary Earnings and Guidance

Valeant Pharmaceuticals International reported mixed preliminary fourth-quarter financial results before the markets opened on Tuesday.

Chris Lange | Mar 14, 2016 at 10:10 AM EDT

What to Expect From Valeant Pharma Q4 Earnings

Valeant Pharmaceuticals is scheduled to report its fourth-quarter preliminary results and update its 2016 financial guidance in a conference call…

Douglas A. McIntyre | Mar 10, 2016 at 6:39 AM EST

Valeant CEO Michael Pearson Should Resign

Valeant Pharmaceuticals International CEO Michael Pearson needs to leave the company he leads, as its problems continue to grow rapidly.

Jon C. Ogg | Mar 8, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AutoNation, Celldex, EP Energy, Shopify, Sony, Urban Outfitters, Valeant and More

The top analyst upgrades, downgrades and initiations seen on Tuesday, March 8, include AutoNation, Celldex Therapeutics, EP Energy, Shopify, Sony,…

Chris Lange | Mar 7, 2016 at 11:20 AM EST

Has Valeant Finally Become More Trustworthy?

In Monday's trading session, it seems that investors are finally coming around and trusting Valeant Pharmaceuticals.

Chris Lange | Mar 6, 2016 at 10:25 AM EST

5 Companies That Destroyed Shareholders Last Week

Although stocks are beginning to make a comeback at this time, there are still those that are caught in the…

Chris Lange | Mar 2, 2016 at 11:05 AM EST

Why Key Analyst Still Sees Upside in Valeant Despite Downgrade

Canaccord Genuity has downgraded Valeant Pharmaceuticals due to the growing uncertainty surrounding its multitude of investigations, both internal and external.

Paul Ausick | Mar 1, 2016 at 4:04 PM EST

The 52-Week Low Club for Tuesday

March 1, 2016: Here are four stocks trading with heavy volume among 44 equities making new 52-week lows today. Valeant…

Jon C. Ogg | Mar 1, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Freeport-McMoRan, PTC, SunEdison, Transocean, UTC, Valeant, Windstream and More

The top analyst upgrades, downgrades and initiations seen on Tuesday, March 1, include Freeport-McMoRan, PTC Therapeutics, SunEdison, Transocean, United Technologies,…

Douglas A. McIntyre | Feb 29, 2016 at 6:22 AM EST

Returning Valeant CEO Pearson Needs to Be Fired

Valeant Pharmaceuticals International Inc. (NYSE: VRX) CEO J. Michael Pearson has returned from sick leave. It is a wonder the board…

Chris Lange | Feb 28, 2016 at 10:40 AM EST

Top 4 Biopharma Movers of the Past Week

Over the past week, Valeant Pharmaceuticals and a few other biotech companies made impressive runs, due to positive trial results…

1 … 6 7 8 9 10 … 13

Valeant Pharmaceuticals Intern... : VRX

All VRX Articles

The 52-Week Low Club for Wednesday

Top Analyst Upgrades and Downgrades: Chipotle, Oracle, Orexigen, PulteGroup, Reynolds American, Valeant and More

Valeant CEO Michael Pearson Has to Leave

The 52-Week Low Club for Tuesday

Valeant Pharma Trips Over Preliminary Earnings and Guidance

What to Expect From Valeant Pharma Q4 Earnings

Valeant CEO Michael Pearson Should Resign

Top Analyst Upgrades and Downgrades: AutoNation, Celldex, EP Energy, Shopify, Sony, Urban Outfitters, Valeant and More

Has Valeant Finally Become More Trustworthy?

5 Companies That Destroyed Shareholders Last Week

Why Key Analyst Still Sees Upside in Valeant Despite Downgrade

The 52-Week Low Club for Tuesday

Top Analyst Upgrades and Downgrades: Freeport-McMoRan, PTC, SunEdison, Transocean, UTC, Valeant, Windstream and More

Returning Valeant CEO Pearson Needs to Be Fired

Top 4 Biopharma Movers of the Past Week

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Valeant Pharmaceuticals Intern... : VRX

All VRX Articles

The 52-Week Low Club for Wednesday

Top Analyst Upgrades and Downgrades: Chipotle, Oracle, Orexigen, PulteGroup, Reynolds American, Valeant and More

Valeant CEO Michael Pearson Has to Leave

The 52-Week Low Club for Tuesday

Valeant Pharma Trips Over Preliminary Earnings and Guidance

What to Expect From Valeant Pharma Q4 Earnings

Valeant CEO Michael Pearson Should Resign

Top Analyst Upgrades and Downgrades: AutoNation, Celldex, EP Energy, Shopify, Sony, Urban Outfitters, Valeant and More

Has Valeant Finally Become More Trustworthy?

5 Companies That Destroyed Shareholders Last Week

Why Key Analyst Still Sees Upside in Valeant Despite Downgrade

The 52-Week Low Club for Tuesday

Top Analyst Upgrades and Downgrades: Freeport-McMoRan, PTC, SunEdison, Transocean, UTC, Valeant, Windstream and More

Returning Valeant CEO Pearson Needs to Be Fired

Top 4 Biopharma Movers of the Past Week

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened